Radiomic signature accurately predicts the risk of metastatic dissemination in late-stage non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and the median overall survival (OS) is approximately 2–3 years among patients with stage III disease. Furthermore, it is one of the deadliest types of cancer globally due to non-specific symptoms and the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilk, Agata Małgorzata, Kozłowska, Emilia, Borys, Damian, D’Amico, Andrea, Fujarewicz, Krzysztof, Gorczewska, Izabela, Debosz-Suwinska, Iwona, Suwinski, Rafał, Smieja, Jarosław, Swierniak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413035/
https://www.ncbi.nlm.nih.gov/pubmed/37577306
http://dx.doi.org/10.21037/tlcr-23-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413035/
https://www.ncbi.nlm.nih.gov/pubmed/37577306
http://dx.doi.org/10.21037/tlcr-23-60

Ejemplares similares